Leveraging on past investment in understanding the immunology of COVID-19 – the South African experience
Keywords:HIV, SARS-CoV-2, vaccine research, immunology, virology
How to Cite
All articles are published under a Creative Commons Attribution 4.0 International Licence
Copyright is retained by the authors. Readers are welcome to reproduce, share and adapt the content without permission provided the source is attributed.
Disclaimer: The publisher and editors accept no responsibility for statements made by the authors